Literature DB >> 1724792

Immunopathologic features of retinal lesions in multiple sclerosis.

M J Lucarelli1, J S Pepose, A C Arnold, R Y Foos.   

Abstract

To further characterize the nature of retinal periphlebitis and retinitis in multiple sclerosis, immunoperoxidase studies were performed on retinal tissue from multiple sclerosis patients at autopsy. Antibodies against myelin basic protein stained the optic nerve but not the retina. Both normal and multiple sclerosis retinas showed staining of Müller cells with Leu-7 (a monoclonal antibody that cross-reacts with myelin associated glycoprotein and natural killer cells). Nerve fiber bundles of the optic nerve in cases with multiple sclerosis and controls also showed staining with Leu-7 antibody. Tissue-bound IgG was demonstrated on retinal ganglion cells in six of seven multiple sclerosis cases but not in controls.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724792     DOI: 10.1016/s0161-6420(91)32080-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Retinal nerve fiber layer and ganglion cell layer changes on optical coherence tomography in early multiple sclerosis and optic neuritis cases.

Authors:  Ganesh Pillay; Anita Ganger; Digvijay Singh; Rohit Bhatia; Pradeep Sharma; Vimla Menon; Rohit Saxena
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

2.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

Authors:  K Kojima; T Berger; H Lassmann; D Hinze-Selch; Y Zhang; J Gehrmann; K Reske; H Wekerle; C Linington
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

Review 3.  Venous endothelial injury in central nervous system diseases.

Authors:  Jonathan S Alexander; Leonard Prouty; Ikuo Tsunoda; Chaitanya Vijay Ganta; Alireza Minagar
Journal:  BMC Med       Date:  2013-10-11       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.